Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 3 institutions in 1 country.
Daniel GündelDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, 04813 Leipzig, Germany.ORCID 0000-0001-9743-2325
Thu Hang LaiDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, 04813 Leipzig, Germany.ORCID 0000-0001-8157-8979
Sladjana Dukic-StefanovicDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, 04813 Leipzig, Germany.
Rodrigo TeodoroDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, 04813 Leipzig, Germany.ORCID 0000-0002-1425-0567
Winnie Deuther-ConradDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, 04813 Leipzig, Germany.ORCID 0000-0003-3168-3062
Magali ToussaintDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, 04813 Leipzig, Germany.ORCID 0000-0002-1136-3857
Klaus KopkaDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, 04813 Leipzig, Germany.ORCID 0000-0003-4846-1271
Rareş-Petru MoldovanDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, 04813 Leipzig, Germany.ORCID 0000-0003-3119-7945
Peter BoknikInstitute for Pharmacology and Toxicology, University of Muenster, 48149 Muenster, Germany.
Britt HofmannCardiac Surgery, Medical Faculty, Martin Luther University of Halle-Wittenberg, 06120 Halle, Germany.
Ulrich GergsInstitute for Pharmacology and Toxicology, Martin Luther University of Halle-Wittenberg, 06112 Halle, Germany.ORCID 0000-0001-6986-485X
Joachim NeumannInstitute for Pharmacology and Toxicology, Martin Luther University of Halle-Wittenberg, 06112 Halle, Germany.
Peter BrustDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, 04813 Leipzig, Germany.ORCID 0000-0001-5555-7058
Helmholtz-Zentrum Dresden-Rossendorf · DEMartin Luther University Halle-Wittenberg · DEUniversity of Münster · DE
Funding
European Regional Development FUND and Sächsische Aufbau Bank 100226753
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Non-Invasive Assessment of Locally Overexpressed Human Adenosine 2A Receptors in the Heart of Transgenic Mice. · full record | OpenQuestion